Question 65

Apidra may substitute for Novolog.

Apidra is an insulin analog that can be used as a substitute for Novolog in the management of diabetes. Both medications are rapid-acting insulin options that help control blood sugar levels during meals.

A) Novolog

Novolog is a rapid-acting insulin that is used to manage blood glucose levels in individuals with diabetes. Apidra and Novolog have similar pharmacokinetic profiles, making Apidra an effective substitute for Novolog in insulin therapy.

B) Namenda

Namenda is a medication used to treat Alzheimer's disease and is not related to insulin or diabetes management. Therefore, it cannot be substituted with Apidra, which is specifically for controlling blood sugar levels.

C) Lovaza

Lovaza is a prescription medication used to lower triglyceride levels and is not related to insulin therapy. As such, it is not a suitable alternative to Apidra, which serves a different purpose in diabetes management.

D) Lanoxin

Lanoxin is a medication used to treat heart conditions, such as atrial fibrillation and heart failure. It is not associated with diabetes treatment and cannot be replaced with Apidra, which is an insulin product.

Conclusion

Apidra is specifically designed to serve as a rapid-acting insulin, making it a suitable substitute for Novolog, which has a similar function in diabetes management. The other options—Namenda, Lovaza, and Lanoxin—are unrelated to insulin therapy and therefore cannot serve as substitutes for Apidra. This confirms that Novolog is the only correct answer in this context.